VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 140 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,886,125 | -73.7% | 144,975 | -64.5% | 0.01% | -74.1% |
| Q1 2024 | $7,159,611 | +62.3% | 408,887 | +101.9% | 0.03% | +42.1% |
| Q4 2023 | $4,410,254 | +9.6% | 202,491 | -22.8% | 0.02% | -20.8% |
| Q3 2023 | $4,023,621 | -30.7% | 262,296 | +7.5% | 0.02% | -27.3% |
| Q2 2023 | $5,805,093 | +29.0% | 244,014 | +37.9% | 0.03% | +10.0% |
| Q1 2023 | $4,500,997 | +31.7% | 176,926 | +51.2% | 0.03% | +3.4% |
| Q4 2022 | $3,417,950 | +188.4% | 117,013 | +102.5% | 0.03% | +123.1% |
| Q3 2022 | $1,185,000 | – | 57,791 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,314,000 | $15,203,000 | 6.46% |
| Ally Bridge Group (NY) LLC | 496,012 | $5,739,000 | 5.23% |
| VR Adviser, LLC | 1,852,919 | $21,438,000 | 4.22% |
| COMMODORE CAPITAL LP | 1,638,609 | $18,959,000 | 4.01% |
| Ghost Tree Capital, LLC | 600,000 | $6,942,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 1,306,569 | $15,117,000 | 3.01% |
| Fairmount Funds Management LLC | 944,092 | $10,923,000 | 2.50% |
| Kynam Capital Management, LP | 590,143 | $6,828,000 | 1.74% |
| Soleus Capital Management, L.P. | 841,018 | $9,731,000 | 1.52% |
| Vivo Capital, LLC | 1,300,000 | $15,041,000 | 1.51% |